老年稳定型心绞痛,药物治疗OR介入治疗

Stable Angina in Elderly Patients:drugs or PCI

由于稳定型心绞痛的病理生理学得到阐明,心绞痛的治疗发生了改变,产生了新的治疗策略。一方面,随着新药物的发展,对心肌缺血的病理生理机制有了更深的认识;另一方面,经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)的持续快速进步也使心绞痛患者治疗有了进一步发展。与非老年人相比,老年人患稳定型心绞痛的治疗策略有其共性,亦有其特殊性,如何根据老年人血管病变特点,在以循证医学为依据的诸多指南实施中,慎重地遵循个体化原则,以使老年稳定型心绞痛患者最大获益,保障其生存质量,是目前老年心血管病研究的重点。

As the pathophysiology of stable angina pectoris been elucidated, angina treatment changed, resulting in a new therapeutic strategies. On the one hand, with the development of new drugs, a deeper understanding of the pathophysiolo- gy of myocardial ischemia~ On the other hand, percutaneous coronary intervention （PCI） and coronary artery bypass graft- ing （CABG） continued rapid progress also has been further developed angina patients. Compared with non--elderly, strat- egies for the treatment of elderly patients with stable angina pectoris has its general character, also has its particularity, according to the characteristics of senile vascular lesions, in evidence--based medicine to guide the implementation of many basis, carefully follow the principle of individuation, so that the elderly patients with stable angina pectoris maximum benefit, to protect their quality of life, is the current research focus of cardiovascular disease in the elderly.